Emmaus Life Sciences, Inc. (EMMA) SEC Filings & Financial Intelligence
Emmaus Life Sciences, Inc. (EMMA) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: EMMA
CIK: 822370
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerWilliam Haddad
Audit LocationCosta Mesa, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-02 | 2025-05-30 | 4 | 0001193125-26-380023 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | CURRENT REPORT | 0001213900-26-089912 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001193125-26-351833 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-15 | CURRENT REPORT | 0001213900-26-057828 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001193125-26-226362 | View SEC Doc Filr Page |
| 3 | 2026-04-21 | 2026-04-16 | 3 Filing | 0001213900-26-046318 | View SEC Doc Filr Page |
| 8-K | 2026-04-17 | 2026-04-16 | CURRENT REPORT | 0001213900-26-045250 | View SEC Doc Filr Page |
| 8-K | 2026-04-14 | 2026-04-13 | CURRENT REPORT | 0001213900-26-043577 | View SEC Doc Filr Page |
| 8-K | 2026-03-31 | 2026-03-30 | CURRENT REPORT | 0001213900-26-036886 | View SEC Doc Filr Page |
| 10-K | 2026-03-31 | 2025-12-31 | 10-K | 0001193125-26-132925 | View SEC Doc Filr Page |
| 8-K | 2026-03-04 | 2026-03-02 | CURRENT REPORT | 0001213900-26-023644 | View SEC Doc Filr Page |
| 8-K | 2025-12-31 | 2025-12-24 | CURRENT REPORT | 0001213900-25-126728 | View SEC Doc Filr Page |
| 8-K | 2025-12-22 | 2025-12-17 | CURRENT REPORT | 0001213900-25-124513 | View SEC Doc Filr Page |
| 8-K | 2025-12-19 | 2025-12-15 | CURRENT REPORT | 0001213900-25-123836 | View SEC Doc Filr Page |
| 8-K | 2025-11-14 | 2025-11-14 | CURRENT REPORT | 0001213900-25-110878 | View SEC Doc Filr Page |
| 10-Q | 2025-11-14 | 2025-09-30 | 10-Q | 0001193125-25-282675 | View SEC Doc Filr Page |
| 8-K | 2025-08-14 | 2025-08-14 | CURRENT REPORT | 0001213900-25-076672 | View SEC Doc Filr Page |
| 10-Q | 2025-08-14 | 2025-06-30 | 10-Q | 0000950170-25-108770 | View SEC Doc Filr Page |
| 8-K | 2025-07-01 | 2025-06-30 | CURRENT REPORT | 0001213900-25-060349 | View SEC Doc Filr Page |
| 8-K | 2025-05-15 | 2025-05-15 | CURRENT REPORT | 0001213900-25-044286 | View SEC Doc Filr Page |
| 10-Q | 2025-05-15 | 2025-03-31 | 10-Q | 0000950170-25-072520 | View SEC Doc Filr Page |
| 8-K | 2025-05-06 | 2025-05-02 | CURRENT REPORT | 0001213900-25-039783 | View SEC Doc Filr Page |
| 8-K | 2025-04-14 | 2025-04-14 | CURRENT REPORT | 0001213900-25-031624 | View SEC Doc Filr Page |
| 10-K | 2025-04-14 | 2024-12-31 | 10-K | 0000950170-25-053744 | View SEC Doc Filr Page |
| NT 10-K | 2025-04-01 | 2024-12-31 | NOTIFICATION OF LATE FILING | 0001213900-25-027099 | View SEC Doc Filr Page |